Suchergebnisse - (Person:"Han, Huan")

PubPharm (147)

31

Correlations of Androgen Receptor Expression with Molecular Subtypes and Clinopathological Features of Invasive Breast Carcinoma of No Special Type in Tibet

enthalten in: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae | 2022

von Luo, H. | Jiang, Y. | BIANbazhaxi | +6

32

Clinical significance of chromosomal integrity in gastric cancers

enthalten in: The International journal of biological markers | 2022

von Zhang, R. | Liu, Z. | Chang, X. | +7

33

Clinical Analysis of ABO-Incompatible Living-Donor Liver Transplantation in Children

enthalten in: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition | 2022

von Han, H. | Dai, X. | Li, Y. | +1

34

Clinicopathological Features of Meningiomas in Tibet

enthalten in: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae | 2022

von Luo, H. | Huo, Z. | Wang, Q. | +8

35

Primary Cutaneous Anaplastic Large Cell Lymphoma:Report of One Case

enthalten in: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae | 2022

von Wang, H. | Guo, P. | Huo, Z. | +1

36

Electrochemical Impedimetric Real-Time Polymerase Chain Reactions Using Anomalous Charge Transfer Enhancement

enthalten in: Analytical chemistry | 2022

von Nobusawa, K. | Han, H. | Takei, F. | +3

37

A village doctor-led multifaceted intervention for blood pressure control in rural China : an open, cluster randomised trial

enthalten in: Lancet (London, England) | 2022

von Sun, Y. | Mu, J. | Wang, D. | +75

CommentIn: Lancet. 2022 May 21;399(10339):1922-1923. - PMID 35500595

38

Paeoniflorin improves the in vitro maturation of benzo(a)pyrene treated porcine oocytes via effects on the sonic hedgehog pathway

enthalten in: Theriogenology | 2022

von Guo, Q. | Li, S. | Wang, X. | +3

39

Retrospective Analysis of Pathological Diagnosis of Central Nervous System Diseases in Tibet

enthalten in: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae | 2022

von Luo, H. | Wang, Q. | Duo, B. | +1

40

Case Report : A good response to furmonertinib second-line treatment of an advanced lung adenocarcinoma patient with a rare EGFR exon 20 N771_P772insH mutation: A case report and literature review

enthalten in: Frontiers in pharmacology | 2022

von Zhang, X. | Han, H. | Zhao, J. | +9